Tata Chemicals declares Q4 & FY25 results; Focuses on core expansion

• Consolidated revenue for the quarter ended March 2025 at ? 3,509 Cr
• Annual sales volume continues to grow (Soda Ash and Bicarb by 6%)
• Board recommends dividend of ? 11 per share

May 07, 2025: Tata Chemicals Limited today declared its financial results for the quarter and year ended March 31, 2025.

Commenting on the results, R. Mukundan, Managing Director & CEO, Tata Chemicals Limited, said, “Market conditions remain challenging even as India continues to grow while China, US and Western Europe are witnessing slight declines due to reduced demand for flat and container glass. In other regions, Asia (excluding China and India) and Americas (excluding USA) demand is robust, while slight decline is observed in demand of Africa. Though demand - supply balance softens, tariff uncertainties will continue to weigh on market, medium- and long-term outlook remains positive driven by sustainability trends.

The company’s overall performance is lower compared to Q4FY24, mainly due to pricing pressure in all geographies.

During the FY25, Company commissioned 230kT Soda Ash and 140kT Bicarb capacity in Mithapur, India. In a move to focus UK operations to high-grade value-added products 70kT pharma grade salt capacity was commissioned in Middlewich, UK.

Our endeavor is to Excel in operations through innovation, digitization and customer delight. We continue our journey to Embed sustainability guided by Project Aalingana. Our focus to Expand the core while being calibrated will also include broadening the portfolio.”

Consolidated Highlights Q4FY25

• Revenue from operations at ? 3,509 Cr, up by 1% compared to Q4FY24, pricing pressure continued in all geographies.
• EBITDA at ? 327 Cr in Q4FY25 as compared to ? 443 Cr in Q4FY24, mainly on account of lower pricing.
• Profit After Tax (before exceptional items and NCI) from continuing operations at ? (12) Cr compared to ? 145 Cr for Q4FY24.
• Soda Ash unit in Lostock, UK ceased it’s operations from early February 2025, resulted in additional exceptional charge of ? 55 Cr.
• Gross debt as on March 31, 2025, stood at ? 7,072 Cr (including lease of ?768 Cr) up by ? 1,509 Cr on account of higher working capital loan in India, US & UK.

Standalone Highlights Q4FY25

• Revenue from operations stood at ? 1,219 Cr, up by 12% compared to Q4FY24.
• EBITDA at ? 230 Cr, up by 20% compared to Q4FY24.
• Profit After Tax from continuing operations was ? 97 Cr, down by 55% compared to Q4FY24 mainly on account of finance cost on NCD.
• Operating working capital improved from 51 days in Q4FY24 to 35 days to Q4FY25.

Consolidated Highlights FY25

• Revenue at ? 14,887 Cr as compared to ? 15,421 Cr in FY24, higher volumes partially offsetting lower pricing.
• EBITDA at ? 1,953 Cr as compared to ? 2,847 Cr in FY24 on account lower margins.
• PAT (before exceptional items and NCI) from continuing operations at ? 479 Cr.
• Exceptional charge of ? 125 Cr consisting of estimated expenses related to employee termination benefits, decommissioning of plant and machinery, and other closure-related incidental expenses, in relation to cessation of Soda ash production at the Lostock plant in Northwich, UK.
• 230kT Soda Ash and 140kT Bicarb facility commissioned in India and 70kT Pharma Grade Salt capacity commissioned in UK.

Standalone Highlights FY25

• Revenue of ? 4,441 Cr as compared to ? 4,384 Cr in FY24, higher volumes partially offsetting lower pricing.
• EBITDA of ? 818 Cr as compared to ? 875 Cr in FY24.
• PAT from continuing operations and before exceptional item of ? 524 Cr as against ? 794 Cr, mainly on account of finance cost on NCD raised to refinance the Singapore debt.

Tata Chemicals Limited - Statement of Standalone Audited Financial Results for the quarter and year ended 31 March, 2025

Tata Chemicals Limited  - Statement of Consolidated Financial Results for the quarter and year ended 31 March, 2025